Gulf Heart Association Conference 2025 in Doha to be hosted by Qatar
The 17th Gulf Heart Association Conference is set to take place from 20 to 22 November 2025 at the Sheraton Grand Doha Resort & Convention Hotel in Doha, Qatar, marking a significant milestone for cardiovascular care advancement in the Gulf region. Organised by the Gulf Heart Association (GHA) in partnership with Hamad Medical Corporation (HMC), the conference is officially CPD Accredited – Category 1, offering a total of 17 CPD credit hours, making it a critical event for healthcare professionals committed to staying abreast of the latest cardiovascular medical developments.
Since its establishment in 2002, the Gulf Heart Association has been the leading non-profit dedicated to fostering excellence in cardiology and cardiovascular surgery across the GCC. Its mission encompasses professional education, scientific research support, and advocacy for heart disease prevention, positioning the GHA as a pivotal force in regional heart health initiatives. The partnership with Hamad Medical Corporation, Qatar’s foremost public healthcare provider, adds significant clinical relevance to the event, ensuring alignment with real-world healthcare priorities and patient care challenges.
This upcoming 17th edition promises to be the most comprehensive yet, featuring over 80 speakers, with a blend of internationally renowned experts and a distinguished local faculty from the Gulf and Middle East. The scientific programme is designed to provide a multifaceted learning environment, including plenary sessions, focused symposia, clinical workshops, and abstract presentations. Key topics span interventional cardiology, heart failure and advanced therapies, electrophysiology and rhythm disorders, cardiovascular imaging, preventive cardiology, cardiac surgery and hybrid procedures, as well as women’s heart health and gender-specific care. This breadth reflects the conference’s commitment to cover cutting-edge research, clinical updates, and practical insights vital to contemporary cardiovascular medicine.
Aside from its scientific and educational remit, the conference plays a vital role in fostering regional and international collaboration. It serves as a nexus for cardiologists, cardiovascular surgeons, researchers, and allied health professionals to exchange knowledge, innovate, and forge partnerships that propel regional cardiovascular care forward. Furthermore, the event prioritises the development of the next generation of cardiovascular specialists, providing opportunities for young researchers and early-career physicians to present their work, receive constructive feedback, and cultivate professional networks.
The choice of Doha as the host city underscores Qatar’s growing prominence as a healthcare and medical education hub in the region. The Sheraton Grand Doha offers a world-class setting suited for a high-profile scientific gathering of this magnitude. Complementing the venue, the conference will include sessions at the Itqan – Clinical Simulation and Innovation Centre, part of the Hamad Medical Corporation, which will facilitate hands-on workshops enhancing the practical skills of attendees.
Adding to the conference’s stature, Khalid Scientific, a leading supplier of advanced laboratory and diagnostic medical equipment in the Gulf region, has been announced as the main sponsor. Their involvement highlights the integration of innovative technology and clinical practice, supporting the event’s focus on best practices and pioneering research.
With cardiovascular disease remaining one of the leading causes of mortality both globally and in the Gulf, the GHA emphasises the importance of education, prevention, and health policy development. The annual conference embodies this mission, bringing together a broad spectrum of stakeholders committed to improving heart health outcomes in the region.
Registration for the 17th Gulf Heart Association Conference is now open, with details and programme highlights available on the official conference website. Healthcare professionals across the cardiovascular field are encouraged to secure their participation in what promises to be a landmark event fostering excellence and innovation in cardiology.